As of 2026-05-16, the Relative Valuation of Brooklyn Immunotherapeutics Inc (BTX) is 535.83 USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.59 USD, the upside of Brooklyn Immunotherapeutics Inc based on Relative Valuation is 6137.8%.
The range of the Relative Valuation is 379.59 - 890.00 USD.
| Range | Selected | |
| Trailing P/E multiples | 25.6x - 59.5x | 42.4x |
| Forward P/E multiples | 25.5x - 32.5x | 29.4x |
| Fair Price | 379.59 - 890.00 | 535.83 |
| Upside | 4319.0% - 10260.9% | 6137.8% |
| Date | P/E |
| 2026-05-14 | 0.59 |
| 2026-05-13 | 0.58 |
| 2026-05-12 | 0.55 |
| 2026-05-11 | 0.56 |
| 2026-05-08 | 0.55 |
| 2026-05-07 | 0.54 |
| 2026-05-06 | 0.55 |
| 2026-05-05 | 0.54 |
| 2026-05-04 | 0.54 |
| 2026-05-01 | 0.54 |
| 2026-04-30 | 0.53 |
| 2026-04-29 | 0.52 |
| 2026-04-28 | 0.51 |
| 2026-04-27 | 0.53 |
| 2026-04-24 | 0.53 |
| 2026-04-23 | 0.51 |
| 2026-04-22 | 0.51 |
| 2026-04-21 | 0.50 |
| 2026-04-20 | 0.50 |
| 2026-04-17 | 0.49 |
| 2026-04-16 | 0.49 |
| 2026-04-15 | 0.49 |
| 2026-04-14 | 0.50 |
| 2026-04-13 | 0.49 |
| 2026-04-10 | 0.48 |
| 2026-04-09 | 0.47 |
| 2026-04-08 | 0.46 |
| 2026-04-07 | 0.45 |
| 2026-04-06 | 0.45 |
| 2026-04-02 | 0.45 |
| 2026-04-01 | 0.45 |
| 2026-03-31 | 0.44 |
| 2026-03-30 | 0.42 |
| 2026-03-27 | 0.43 |
| 2026-03-26 | 0.44 |
| 2026-03-25 | 0.45 |
| 2026-03-24 | 0.44 |
| 2026-03-23 | 0.44 |
| 2026-03-20 | 0.43 |
| 2026-03-19 | 0.44 |
| 2026-03-18 | 0.43 |
| 2026-03-17 | 0.43 |
| 2026-03-16 | 0.43 |
| 2026-03-13 | 0.42 |
| 2026-03-12 | 0.42 |
| 2026-03-11 | 0.43 |
| 2026-03-10 | 0.43 |
| 2026-03-09 | 0.43 |
| 2026-03-06 | 0.43 |
| 2026-03-05 | 0.44 |